Device Delivers Gene Therapy for Lung Disease

Drug-delivery researchers have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis. In cell culture and mouse models, scientists demonstrated a novel technique for the aerosolization of inhalable nanoparticles that can be used to carry messenger RNA, the technology underpinning COVID-19 vaccines, to patients’ lungs.